6533b836fe1ef96bd12a0503

RESEARCH PRODUCT

RESISTANCE TO VANDETANIB IN MEDULLARY THYROID CARCINOMA: POSSIBLE NEW TREATMENT

Concetta Baiamonte

subject

THYROIDMEDULLARYTREATMENT RESISTANCESettore MED/13 - Endocrinologiahttps://hdl.handle.net/10447/594715